Overview

Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.
Phase:
Phase 2
Details
Lead Sponsor:
Alcon Research
Treatments:
Anecortave
Hydrocortisone